EFFECTS OF PYRROLOQUINOLINE QUINONE (PQQ) SUPPLEMENTATION ON NON-ENDURANCE TRAINED ATHLETES

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

August 15, 2025

Study Completion Date

August 15, 2025

Conditions
Mitochondrial BiogenesisInflammation
Interventions
DIETARY_SUPPLEMENT

Pyrrole Quinoline Quinone (PQQ)

Subjects will be provided with 84 capsules of the PQQ or the placebo supplement. Both supplements were in capsule form and identical in size, shape and color. The PQQ content per capsule was 10 mg. The indication was to take two capsules every evening for 6 weeks. The duration of the supplementation protocol was assessed based on a previous study (Hwang et al., 2020), while the dose was chosen according to EFSA recommendations (Turck et al., 2017).

OTHER

Placebo

Subjects were provided with 84 capsules of placebo. The indication will be to take two capsules every evening for 6 weeks.

Trial Locations (1)

35131

Nutrition and Exercise Lab, DSB, University of Padova, Padua

All Listed Sponsors
lead

University of Padova

OTHER

NCT07148726 - EFFECTS OF PYRROLOQUINOLINE QUINONE (PQQ) SUPPLEMENTATION ON NON-ENDURANCE TRAINED ATHLETES | Biotech Hunter | Biotech Hunter